Earnings · China A-shares
Lionco Pharmaceutical Group Co., Ltd. Class A (603669) earnings
Lionco Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit +192.24% year on year, +141.81% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -13.65% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- +192.24%
- Excl. one-offs YoY
- +141.81%
- Net profit QoQ
- -40.99%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +4.30% | — |
| 3 days | -13.65% | — |
| 7 days | -23.00% | — |
| 14 days | -16.91% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 5 of 7 reports (average +0.76%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥31.83M | +192.24% | +141.81% | +27.79% | 0.04 | 5.00% | -13.65% | — | — |
| 2026 interim report | 2026-08-15 | ¥21.11M | +159.08% | +140.45% | +50.03% | 0.03 | 3.35% | -6.20% | -6.20% | +0.41% |
| 2026 Q1 report | 2026-04-29 | ¥2.96M | +115.87% | +105.66% | +72.65% | 0.00 | 0.47% | +3.67% | +7.57% | +6.62% |
| 2025 annual report | 2026-04-29 | -¥193.24M | -47.78% | +5.59% | -15.09% | -0.27 | -28.91% | +3.67% | +7.57% | +6.62% |
| 2025 Q3 report | 2025-10-31 | -¥34.50M | +26.42% | +37.87% | +22.00% | -0.05 | -4.59% | +2.93% | -13.89% | -9.21% |
| 2025 interim report | 2025-08-23 | -¥35.73M | +11.55% | +16.31% | +21.30% | -0.05 | -4.75% | +11.42% | -5.27% | -10.14% |
| 2025 Q1 report | 2025-04-26 | -¥18.62M | -16.08% | +12.27% | -34.79% | -0.03 | -2.45% | +3.20% | +23.06% | +19.81% |
| 2024 annual report | 2025-04-19 | -¥130.76M | +13.68% | +0.91% | +92.95% | -0.18 | -15.32% | +3.96% | +24.01% | +21.06% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.